• On Average, 5,400 active patients visit the hospital each year, most of whom are treated on an outpatient basis. 

• Research findings at St. Jude are shared freely with doctors and scientists all over the world.  St. Jude enjoys a worldwide reputation as a teaching facility.  The medical and scientific staff published more than 600 articles in academic journals in 2007, more than any other pediatric cancer research center in the United States.  This is an average of a St. Jude paper being published every 17 hours. 

• St. Jude is the only pediatric cancer research center where families never pay for treatment not covered by insurance.  No child is ever denied treatment because of the family’s inability to pay. 

• St. Jude was the first institution to develop a cure for sickle cell disease with a bone marrow transplant and has one of the largest pediatric sickle cell programs in the country.

• The daily operating cost for St. Jude is nearly $1.3 million, which is primarily covered by public contributions.

• In addition to providing medical services to eligible patients, St. Jude also assists families with transportation, lodging, and meals.

• St. Jude pioneered a combination of chemotherapy, radiation and surgery to treat childhood cancers.

• In 1962, the survival rate for acute lymphoblastic leukemia (ALL), the most common form of childhood cancer, was 4 percent.  Today, the survival rate for this once deadly disease is 94 percent, thanks to research and treatment protocols developed at St. Jude.

• St. Jude is the first and only pediatric cancer center to be designated as a Comprehensive Cancer Center by the National Cancer Institute. 

• St. Jude has developed protocols that have helped push overall survival rates for childhood cancers from less than 20 percent when the hospital opened in 1962 to more than 70 percent.